期刊名称：INTERVENTIONAL NEURORADIOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
About INR
Description - Interventional Neuroradiology is an international cross-disciplinary journal devoted to the study of diagnostic and therapeutic neuroradiology and related neurosciences. The discipline encompasses all those low invasive therapeutic techniques variously known as therapeutic neuroradiology, endovascular surgery, endovascular neurosurgery, etc. Interventional or therapeutic neuroradiology is not confined to endovascular procedures. It is an umbrella term embracing many treatments ranging from percutaneous nucleotomy to stereotactic biopsies and radiosurgery and an array of allied or overlapping disciplines from intensive care to physiology and embryology. The fact that all the procedures are performed in a radiological unit using a neuroradiological approach is the reason we chose this name for the journal. Interventional Neuroradiology aims to provide a forum to exchange news and views on all aspects of this fascinating new field of medicine. The journal publishes original papers, review papers, opinions and case reports (commented by the editors) and congress announcements. A special section will be devoted to "how-to-do- it" professional news. Other features include a commented review of the literature, a "library corner", biographical sketches of leading figures and contributions on ethical issues and the cost- benefit debate.
Presentation - Centauro srl founded the Rivista di Neuroradiologia in 1988. Started as an independent journal, it became the official journal of the Italian Society of Neuroradiology. During this wonderful experience we realized the need for an independent journal devoted to interventional neuroradiology and related sciences. Marco Leonardi and Pierre L. Lasjaunias founded Interventional Neuroradiology in 1995, and presented it at the WFITN Meeting in Kyoto the same year. INR has been designed to be thee ideal forum open to all specialists working in this field to debate, report, learn and understand what interventional neuroradiology is and most of all what it could or should be as well as the corpus of knowledge needed to work within this special field of medicine. Interventional Neuroradiology has its own approach which is not purely technical, but patient-focused. This is not only the journal's ethos, but a suggestion to all who are involved or will be or would like to be involved in this field. Mastering a technique is extremely important and certainly the logical basis of the neuroradiologist's work, but it is not enough. We need to know more about other disciplines from physiology, embryology, pathology and anatomy to intensive care, neurosurgery and neurology to be able to act as physicians and not as just technicians despite being experts in special or acrobatic procedures. Interventional Neuroradiology is designed as a worldwide independent scientific journal. In 2009 Interventional Neuroradiology and AJNR the American Journal of Neuroradiology signed an important cooperation agreement. SINCE 2011, Interventional Neuroradiology will be available also in digital edition.
Official journal of
- WFITN - World Federation of Interventional and Therapeutic Neuroradiology
- AAFITN - Asian & Australasian Federation of Interventional & Therapeutic Neuroradiology
- SAWITN - South American Working Group in Interventional Therapeutic Neuroradiology
- Sponsored by JSNET - Japanese Society of Neuro Endovascular Therapy
Interventional Neuroradiology is published quarterly with 1,900 copies distributed all over the world.
Indexed in:
- EMBASE (http://www.scopus.com);
- Expanded (SciSearch®);
- ISI - Institute for Scientific Information: Neurosciences Citation Index®, ISI Alerting Services®, and Science Citation Index®
- Google Scholar (http://scholar.google.com);
- National Library of Medicine's MEDLINE database (http://www.ncbi.nlm.nih.gov/pubmed/ - Search: interv neuroradiol).
- WFNRS - Library of the SIIC - SociedadIberoamericana de InformaciónCientífica;
Impact Factor: June 2012 - 0,773
Founders: Pierrre L. Lasjaunias and Marco Leonardi
I would now like to emphasize some important technical points:
- All articles published in the INR will be available on the journal's website and can be downloaded by subscribers.
- Authors are encouraged to submit their papers to the INR via the website: http://in.edmgr.com, but manuscripts can be sent by e-mail or post if electronic submission is not possible.
Editor-in-Chief:
Karel ter Brugge - Diagnostic and Interventional Neuroradiology
Toronto Western Hospital- 339, Bathurst Street M5T 2S8 Toronto Canada
e-mail: karel.terbrugge@uhn.on.ca
Assistant Editor:
Prof. Timo Krings
Diagnostic and Interventional Neuroradiology
Toronto Western Hospital
339, Bathurst Street
M5T 2S8 Toronto Canada
e-mail: timo.krings@uhn.on.ca
Editorial Board
Michel Mawad, Luc Picard
Corresponding Editors
Alex Berenstein, Robert Kwok, Luis A. LemmePlaghos, Akira Takahashi, Anton Valavanis, Fernando Viñuela
Advisory Board
Z. Bien, J.-F. Bonneville, G.B. Bradac, P. Burrows, A. Casasco, I.S. Choi,H. Deramond, J. Dion, L. Feng,A. Fox, K. Goto, G. Guglielmi, V. Halbach, H. Houdart, D. Kuehne, J.F. Meder, J.J. Merland, A. Molyneux, J. Moret, P.H. Nakstad, M. Negoro, L.R. Piske, B. Richling, G. Rodesch, Ch. Strother, P. Svendsen, S. Suthipongchai, A. Takahashi, W. Taki, J. TevahCastello, J. Theron, B. Willinsky, H. Zeumer
Publishing Staff
Publisher
Nicola Leonardi
Direttore responsabile
Centauro s.r.l.
Via del Pratello, 8
I-40122 Bologna, Italy
Language Editor
Anne Collins
E-mail: collins@iol.it
Graphic and Paging
Elisabetta Madrigali
E-mail: elisabetta@centauro.it
Advertising and Subscriptions
Serena Preti
E-mail: serena.preti@centauro.it
For Information:
Centauro s.r.l.
Via del Pratello, 8
I-40122 Bologna, Italy
Tel: ..39.051.227634
Fax: ..39.051.220099
SINGLE ISSUE: Euro 46,00
Back Issues: 50% surcharge
Reg. Trib. di Bologna n. 7636 del 16/06/06
ISSN 1591-0199
Instructions to Authors
Instructions To Authors
First formulated in November 1995
Revised in January, 2013
Interventional Neuroradiology (INR) is a clinical practice journal documenting the current state of diagnostic and interventional neuroradiology worldwide. INR publishes original clinical observations, descriptions of new techniques or procedures, case reports, and articles on the ethical and social aspects of related health care. Original research published in INR is related to the practice of neuroradiology. Submissions suitable for the Journal include observational studies, clinical trials, epidemiological work, reports on health services and outcomes, and advances in applied (translational) and/or basic research.
The instructions for submission of articles to INR follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of the International Committee of Medical Journal editors (ICMJE, http://www.icmje.org), if not otherwise indicated below.
RESEARCH AND PUBLICATION ETHICS
Conflict of interest policies
Interventional Neuroradiology (INR) upholds high standards of integrity and ethical conduct in research, and related communications. It is important that the editors, authors, and reviewers conduct themselves in accordance with rigorous standards and transparent policies for addressing potential conflicts of interest. Herein, we delineate what constitutes a potential conflict of interest for the INR as it relates to editors, authors, and reviewers.
Those found in violation of these policies may be subject to sanctions as determined by the INR editors.
Editorial conflicts of interest
The INR editors are responsible for maintaining high standards in evaluating contributions and maintaining the integrity of the Journal. In the interest of establishing full transparency, editors are obliged to disclose any and all potential conflicts of interest to the INR. We have determined two tiers of potential conflict and corresponding actions to be taken. The editors will report changes to their potential conflicts as they occur. An annual formal review of all disclosures will be performed in the evaluation of compliance.
The first tier of potential conflicts for editors:
(1) Ownership. If an editor currently has direct ownership of equity in a private or public company in the health care field of $10,000 or more (including restricted stock; the market price of all options, vested or unvested; and warrants), a first-tier potential conflict must be declared. Interests held by immediate family members (spouse or children) of the editor are included. This does not apply to ownership of mutual funds, where the editor does not directly control the purchase and sale of stocks.
(2) Income. If an editor has received $10,000 or more per annum of income from any single private or public company in the health care field in the preceding calendar year, a first-tier potential conflict must be declared. This includes any and all sources of financial benefit, including, but not limited to, consultancy, speaking fees, royalties, licensing fees, retainers, salary (including deferred compensation), honoraria, service on advisory boards, and providing testimony as an expert witness. Income generated by immediate family members (spouse or children) of the editor is included.
(3) Research support. If an editor’s research was funded by $50,000 or more per annum from a private or public company in the health care field in the preceding fiscal year, including funding for personnel working within the laboratory, a first-tier potential conflict must be declared.
If an editor declares a first-tier potential conflict relating to (1), (2), or (3), this information will be published on the INR website. An editor will be considered to be in conflict if a manuscript is funded solely by an organization with which the editor has a potential conflict, regardless of whether a research institution employs the authors.
The second tier of potential conflicts for editors:
(4) Relationship with a company. If an editor had a relationship with a private or public company in the health care field wherein the editor received some compensation for services, but the total amount of income was between $1,000 and $9,999 for the preceding calendar year, a second-tier potential conflict must be disclosed. This includes, but is not limited to, any compensation as detailed above in (2).
(5) Relatives. If an editor has a close relative other than a spouse or child (sibling or parent) employed by or with a significant financial interest in a private or public company in the health care field, a second-tier potential conflict must be declared.
(6) Prospective employment. If an Editor is negotiating with, has arranged prospective employment with, or is expected to initiate a significant financial relationship as defined in (1), (2), or (3) with a private or public company in the health care field, a second-tier potential conflict must be declared.
(7) Personal. Editors will be required to declare a second-tier potential conflict if a manuscript is submitted by a close personal contact (former student, fellow or mentor, for example) or a recent collaborator (over the last 3 years). Relevant collaborations may include co-authoring a research article or serving as co-investigators on a grant.
(8) Competition. Editors will be required to declare a second-tier potential conflict if a submitted manuscript presents data that are highly relevant to a manuscript the Editor has under review or in press elsewhere. Editors are prohibited from using unpublished information from the manuscripts under consideration by the INR to further their own research, nor can they use new information gained from unpublished manuscripts for financial gain.
(9) Personal benefit. The editor must avoid making a decision on a manuscript if he or she could benefit personally from its disposition.
The second tier of potential conflicts will necessitate only internal disclosure to the editorial board. These potential conflicts will not be published, but they will be known to the INR staff and other INR editors. The editor in potential conflict will not make decisions related to the manuscript.
All editors will have access to a list of the first- and second-tier potential conflicts. Editor in Chief is responsible for recording and updating all potential conflicts. The Editor in Chief reviews any INR editorial staff potential conflicts.
We are aware that other potential issues may arise, and these will be evaluated by the Editor in Chief on a case-by-case basis.
INR editors are discouraged from serving as editors for other neuroradiology journals for which they would make final decisions on manuscripts. All such editorial duties for other journals must be approved by the Editor in Chief.
In order to avoid even the appearance of potential favoritism to institutional colleagues, manuscripts from Editors’ institutions will not be handled by the editorial board at large, but instead in a separate process. In these circumstances, a specific Editor will be the only editor privy to the manuscript and, if the manuscript is sent for review, will work with an outside consultant to formulate a decision.
Author conflicts of interest
All authors are expected to disclose all financial relationships that could undermine the objectivity, integrity, or perceived value of a publication. The editors will keep the potential conflicts in mind while evaluating the manuscripts.
Authors must disclose all potential conflicts as described below even if they believe their conflict is not germane to the content of the submitted paper (these correspond to the first tier of potential conflicts defined for editors). Such potential conflicts will be published in a footnote if the manuscript is ultimately accepted. It is the responsibility of the corresponding author to gather the list of potential conflicts from each author and to communicate the list of all potential conflicts to the editors with the submission.
Potential conflicts to be disclosed by authors:
(1) Ownership. If an author currently has direct ownership of equity in a private or public company in the health care field of $10,000 or more (including restricted stock; the market price of all options, vested or unvested; and warrants), a first-tier potential conflict must be declared. Interests held by immediate family members (spouse or children) of the author are included. This does not apply to ownership of mutual funds, where the author does not directly control the purchase and sale of stocks.
(2) Income. If an author has received $10,000 or more of income per annum from any single private or public company in the health care field in the calendar year preceding the date of the original submission, a potential conflict must be declared. This includes any and all sources of financial benefit, including, but not limited to, consultancy, speaking fees, royalties, licensing fees, retainers, salary (including deferred compensation), honoraria, service on advisory boards, and providing testimony as an expert witness. Income generated by immediate family members (spouse or children) of the author are included.
(3) Research support. If an author’s research was funded by $50,000 or more per annum from a private or public company in the health care field in the fiscal year preceding the date of the original submission, including funding for personnel working within the laboratory, a potential conflict must be declared.
Reviewers’’ conflicts of interest
Reviewers should exclude themselves in cases where there is a material potential conflict of interest, financial or otherwise. We ask that reviewers inform the editors of any potential conflicts that might be perceived as relevant as early as possible following invitation to participate in the review, and we will determine how to proceed. Disclosing a potential conflict does not invalidate the comments of a reviewer, it simply provides the editors with additional information relevant to the review.
We ask reviewer to use their judgment in responding to our request for full disclosure, basing their response to the editors on the same financial criteria applied to authors and editors, as described above.
1. Author responsibility for originality: The corresponding author acknowledges responsibility for the integrity of the manuscript, assures the originality of the paper, and guarantees that submitted manuscripts do not contain previously published material and are not under consideration for publication elsewhere. If the submitted manuscript builds on or includes parts of previously published articles, authors are encouraged to enclose copies of the articles with the new submission. The Editors reserve the right to request the original data obtained in the investigation
2. Registration of clinical trial research: Any research that includes clinical trials should be registered with the primary national clinical trial registration authority accredited by WHO (http://www.who.int/ictrp/network/primary/en/index.html) or ICMJE.
3. Disclosure statement: This is not intended to prevent authors with potential conflicts of interest from contributing to INR. Rather, the Journal will place on record any relationship that may exist with disclosed, or competing, products or firms. Disclosed information will be held in confidence during the review process and the Editors will examine any printed disclosure accompanying a published article. Authors are responsible for notifying the Journal of financial arrangements including, but not limited to, agreements for research support including provision of equipment or materials, membership of speaker bureaus, consulting fees, or ownership interests. It is important that disclosure statements be updated promptly to reflect any new relationships that arise after initial submission of the manuscript. If the study is supported by a commercial sponsor, the authors must document the input of the sponsoring agency in study design, data collection, analysis of results, interpretation of data, and report writing. It is important to specify whether the sponsors could have suppressed or influenced publication if the results were negative or detrimental to the product they produce. Authors should also state if the company was involved in the original study design, the collection and monitoring of data, analysis and/or interpretation, and/or the writing and approval of the report.
4. Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity is carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and followed all the guidelines for experimental studies with human subjects required by the institution(s) with which all the authors are affiliated. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, images, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. If identifying characteristics are altered to protect anonymity, authors should provide assurance that alterations do not distort scientific meaning and editors should be noted.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material and not the INR.
5. Statement of human and animal rights: When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2005. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed. All biomedical research performed on subjects should be in accordance with international ethic rules and approved by local ethic committees. Randomized clinical trial reports must be written in accordance with the CONSORT reporting guidelines (The Consolidated Standards of reporting Trials)
6. Duplicate/Redundant publication: INR only accepts manuscripts describing original research. The editorial office of the INR does not accept duplicate submission or redundant publication. Redundant (or duplicate) publication is publication of a paper that overlaps substantially with a paper already published in print or electronic media as defined by the updated ICMJE guidelines that cover allegations of scientific misconduct. When submitting a paper, authors should make a full statement to the Editor on all submissions and previous reports that might be regarded as redundant publication of the same or similar work. If authors believe that their manuscript may be considered redundant, they should address this issue in a letter to the Editor accompanying the submission. The authors should also explain in the letter how their report overlaps already published material, or how it differs. Copies of such published material should be included with the submitted paper to help the Editor examine the possibility of redundant publication. If redundant publication is attempted without such notification, authors should expect editorial action to be taken. At the very least, rejection of the manuscript may be expected.
7. Authorship: The Editors consider authorship to belong to those persons who accept intellectual and public responsibility for the statements made and results reported. By submitting a manuscript for publication, each author acknowledges having made a substantial contribution to the concept and design of the study, the analysis and interpretation of the results, and the writing of the paper, in addition to having approved the final submitted version. Authorship should not be attributed to Departmental Chairs not directly involved in the study, to physicians or technicians who provided routine services, or to technical advisors. A group study should carry the group name and reference contributing authors in the Acknowledgments.
PEER REVIEW PROCESS
Papers are accepted on the understanding that they are subject to peer review, editorial revision, and, in some cases, comment by the Editors. Manuscripts are examined by independent peer reviewers. Articles and other material published in the Journal represent the opinions of the authors and should not be construed to reflect the opinions of the publisher.
LANGUAGE
The official language of INR is English. Most papers in INR have been written by non-native English speakers, and they will also be read by many non-native speakers. For the purposes of clarity, it is strongly recommended that authors not fluent in English have their manuscript professionally edited for English usage prior to submission. A professional editor will improve the English to ensure that author meaning is clear and to identify problems that require author review. Authors are invited to contact the INR language editor Anne Collins (collins@iol.it) for referral to professional English language editing services. Authors should make contact with and arrange payment to their chosen editing service directly. Please note that the use of such a service is at the author's own expense and risk and does not guarantee that the article will be accepted for publication. Centauro Publishers does not receive any commission or other benefit from editing services. Accordingly, Centauro Publishers neither endorses nor accepts any responsibility or liability for such editing services.
COPYRIGHT AND PURCHASE OF OFFPRINTS
All articles published in INR are protected by copyright, which embraces the exclusive right to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in the Journal may be reproduced without written permission from the publisher. INR offers authors a complimentary hard copy and .pdf file of the issue in which their article is published, for personal use. To purchase offprints of articles published by INR please contact Centauro Srl for a quotation at serena.preti@centauro.it.
PUBLICATION TYPES
Original Research Articles are full-length research papers, which are favored by INR. Articles cover topics relevant to clinical studies, and may include both basic and experimental work.
Review Articles are comprehensive, state-of-the-art papers focusing on important clinical problems and should address a specific topic in a scholarly manner. Such articles may be invited by the Editor or may be unsolicited reviews.
Case Reports/Technical Notes should be unusually educational and medically important. Although INR preferentially encourages submission of full-length Original Research Articles, the Journal will consider publication of a limited number of concise Case Reports and Technical Notes.
Editorials are usually invited by the Editor.
Editorial Comments are specific comments on the articles published in INR and are usually invited by the Editor.
Letters to the Editor contain constructive comments or criticism of a specific paper published by INR. Letters dealing with subjects of general interest within the field of INR, or personal opinions on a specific subject within the ambit of INR, may also be accepted.
ELECTRONIC SUBMISSION OF MANUSCRIPTS
INR provides an electronic submission system (Editorial Manager) and review process to promote expeditious peer review. Manuscripts should be submitted electronically to the following URL: http://www.editorialmanager.com/in/. Questions about manuscripts under consideration may be addressed to the editorial office.
The corresponding author listed on the manuscript must complete the forms in Editorial Manager, entitled Conflicts of Interest/Disclosures, Copyright Transfer Agreement, Financial Support, Exclusive Publication Statement, and Author Contribution Form. Submissions not containing completed forms by the corresponding author will not progress to peer review. Prior to submitting any paper, please follow the instructions given below. Please note that an author must have an e-mail address to use the online submission system.
MANUSCRIPT PREPARATION
Introductions that Satisfy Reader Expectations
Overview: Once you have a revised draft, you need to ensure that your Introduction frames it, so that your readers will understand where you are taking them. The Introduction should orient readers and motivate them to read the rest of the paper. The Introduction must also make a contract with the reader that a question will be answered.
Functions: – To awaken the reader’s interest .– To be informative enough to prepare readers to understand your paper.
Content and Organization: 1. Common ground - Context - Relevant background - Orients the reader. - 2. Disruption - Problem - Gap in Knowledge, Question - Motivates the reader. - 3. Resolution - Response - Promise of an answer - Makes a contract with the reader.
1. Common Ground – States the consensus, shared understanding, common ground in the field, what’s know and not known. – Gives the reader context and provides relevant background information, not a literature review.
2. Disruption – States the problem/the question that the paper addresses. – Conveys the significance, i.e. the cost of leaving problem unsolved, or the benefit of solving it.
3. Resolution – Implicitly promises that you will present your answer in the Results and Discussion. – Try not to state the answer; that has the effect of closing off the paper rather than leading into it.
When drafting: – Although the Introduction unfolds in the above order, 1-2-3, when you’re drafting, write it in a 3-2-1 order – By writing the Introduction in this order, you are sure to work through and clearly set up your main point, the question that it answers, and to include only relevant background information.
When revising: – “The key is to think like a reader -- readers expect and need a sense of structure. Since readers read each sentence in light of how they see it contributing to the whole, when you revise it makes sense to diagnose first the largest elements of the paper, then focus on the coherence of your paragraphs, the clarity of your sentences, and only last on matters of spelling and punctuation. Of course, in reality, no one revises so neatly; all of us revise as we go. But, it is useful to keep in mind that when you revise from the top down, from global structure to sections to paragraphs to sentences to words, you are more likely to discover useful revisions than if you start at the bottom with words and sentences and work up”. Booth WC, Colomb GG, Williams JM, et al. The Craft of Research. Chicago: University of Chicago Press; 2008.
Original research should be organized in the customary format, as described below. The text of the manuscript should be submitted as a single document with the following sections (in order):
1. Author Information Page (First page)
Full title of the article, authors' names, highest academic degree earned by each author, authors' affiliations, name and complete address for correspondence, address for reprints if different from address for correspondence, fax number, telephone number, and e-mail address.
2. Acknowledgments and Funding Page (Second page)
The Acknowledgments section lists all funding sources for the research of the study, and details substantive contributions of individuals. The authors must reveal all possible Conflicts of Interest/Disclosures.
3. Title Page (Third page)
The full title, itemized list of the number of tables, the number and types (color or black-and-white) of figures, and three-to-five key words for use as indexing terms should be included. Appropriate key words should be selected from the Medical Subject Heading. The word count of the text should be specified.
4. Summary
A summary of up to 250 words should summarize the problems presented and describe the studies undertaken, results and conclusions. Since the abstract must be explicative, the abbreviations must be reduced to a minimum and explained. References should not be cited in the abstract.
5. Text
Typical main headings include Introduction, Materials and Methods, Results, Discussion, and Conclusions. Abbreviations must be defined at first mention in the text, tables and figures. The complete names and short addresses of manufacturers of any equipment used in Materials and Methods must be supplied. If animals are used in experiments, state the species, the strain, the number of animals used, and any other pertinent descriptive characteristics. If human subjects or patients are employed, provide a table with relevant characteristics. When describing surgical or neurointerventional procedures on animals, identify the pre-anesthetic and anesthetic agents used, and state the amount or concentration and the route and frequency of administration of each agent. Generic names of drugs must be given. Manuscripts that describe studies on humans must indicate that the study was approved by an Institutional Review Committee and that all subjects gave informed consent. Reports of studies on both animals and humans must indicate that all procedures followed were in accordance with institutional guidelines.
6. References
Citations should be listed in order of appearance in the text, and between square brackets [ ]. References must be listed at the end of the text in the order of citation. Journal titles should be abbreviated according to Index Medicus. For citation rules not specified here, authors should refer to the NLM Style Guide for Authors, Editors, and Publishers (http://www.nlm.nih.gov/citingmedicine). All references must be checked by the author(s).
Journal article:
Laredo JD, Bard M. Thoracic spine: percutaneous trephine biopsy. Radiology. 1986; 160: 485-489.
Journal article if the number of authors is more than three: list the first three authors followed by et al.
Geibprasert S, Krings T, Pereira V, et al. Clinical characteristics of dural arteriovenous shunts in 446 patients of three different ethnicities. Intervent Neuroradiol. 2009; 15: 395-400.
Entire book:
Valavanis A. Medical radiology: interventional neuroradiology. Heidelberg: Springer Verlag; 1993.
Part of book if number of authors is more than two:
Bonneville JF, Clarisse J, et al. Radiologie interventionnelle. In: Manelfe C ed. Imagerie du rachis et de la moelle. Paris: Vigot Editeur; 1989. p. 761-776.
7. Tables
Each table must be typed on a separate sheet and double-spaced, if possible. Tables should be numbered using the Arabic system, followed by a brief informative title. Use type of the same font and size as employed in the text. Include footnotes at the bottom of each table. Tables must be numbered in the order cited in the text. Tables should not duplicate data given in the text or figures.
8. Figure Legends
Provide figure legends on a separate sheet. Legends must be double-spaced, and figures must be numbered in the order cited in the text.
9. Figures
Figures should preferably be submitted online in .tiff format to: http://nrj.edmgr.com. The time required to send files will vary depending on the number of figures, but image resolution must not be reduced to decrease transmission time. When labeling the figures, please ensure that the label corresponds to the figure number.
Digital images (originals or images acquired by a scanner) must meet the following criteria:
- Black-and-white figures: Images must be acquired using the grey scale with a minimum resolution of 300 pixels per inch or 150 pixels per cm. Images must have a base of at least 8.1 cm for one item or a minimum base of 16.9 cm for several items.
- Color figures: Images must be acquired using the full color CMYK method with
- A minimum resolution of 300 pixels per inch or 150 pixels per cm. Images must have a base of at least 8.1 cm for one item or a minimum base of 16.9 cm for several items. The RGB method is recommended for video reproductions only, as the quality of printed figures is poor.
Images must be saved in .tiff format. Images in .jpg format are not acceptable as details tend to be lost upon scanning, even at high resolution. Image definition also depends on the enlargement factor. Thus, a large low-resolution image can be proportionally reduced (by 24%) for publication, thereby permitting optimal presentation in print. However, enlargement of a small high-resolution image will highlight all flaws, yielding a pixelated effect.
Do not submit figures already paged in Word, PowerPoint, or other documents, or images inserted in web pages. Such images are of low resolution and are unsuitable for printing.
Figures in .dcm (Dicom) format may be submitted as .dcm or .tiff files. The editorial office will process such images for printing.
Illustrations may be compressed using the StuffIt, Aladdin, or Zip programs.
Do not label an image with arrows, numbers, or letters, but rather indicate on a duplicate copy or a sketch where such indications are desired.
Authors are advised to refer to the Journal guidelines when formatting their work. Otherwise the editorial office may return a submission to the authors for improvement before any Editor is assigned.
If it is not possible to send figures via the Internet, images may be sent by express courier in one of the following formats:
- Original x-ray films, slides, or glossy or opaque prints. Clearly indicate on the back of the image the first author's name and the number corresponding to the figure caption and citation in the text.
- Figures may be submitted on a CD-ROM or DVD, copied in ISO9006 format legible on both PC and MAC. Floppy disks are not recommended. Clearly indicate on one side of the figure both the top of the figure and the figure number. Do not label the actual image with arrows, numbers, or letters, indicate the top and figure number on a duplicate copy or on a sketch. Do not cut or attach figures with adhesive tape or use paper clips. If images are sent offline, thumbnails of the images should be uploaded as a submission item online, together with the manuscript, to allow the publishers to reserve space for the original high-resolution images. Authors are reminded that manuscripts must be sent online via Editorial Manager even when authors choose off-line figure submission.
- In case of difficulties or problems please contact: Prof. Marco Leonardi marco.leonardi@centauro.it
All off-line material should be sent to the editorial office:
Interventional Neuroradiology
Centauro S.R.L.
Via del Pratello, 8
I-40122 Bologna – Italy
Email: marco.leonardi@centauro.it
Instructions for Authors and Commentators
Interventional Neuroradiology (INR) is a unique scientific communication medium, providing the service of Open Peer Commentary for reports of significant current work in diagnostic imaging and neuroradiological sciences. If a manuscript is judged by INR referees and editors to be appropriate for Commentary (see Criteria below), it is circulated electronically to a large number of commentators selected (with the aid of systematic bibliographic searches and e-mail Calls for Commentators) from the carefully selected INR Associates and the worldwide science community, including individuals recommended by the author. If you are not a INR Associate and wish to enquire about joining, please see the instructions for subscribers membership at http://interventionalneuroradiology.centauro.it/catalogo_prodotti.aspx. Once the Commentary stage of the process has begun, the author can no longer alter the article, but can respond formally to all commentaries accepted for publication. The target article, commentaries, and authors’ responses then co-appear in INR.
Criteria for acceptance: To be eligible for publication, a manuscript should meet the standards of journals such as Radiology, American Journal of Reontgenology and American Journal of Neuroradiology in terms of conceptual rigor, empirical grounding, and clarity of style. Author can also offer an explicit 500 word rationale for soliciting Commentary, and a list of suggested commentators (complete with e-mail addresses).
A INR target article can be:
1. The report of major studies and discussion of empirical research that the author judges to have broader scope and implications across disciplines.
2. An unusually significant theoretical article that formally models or systematizes a body of research.
3. A novel interpretation, synthesis, or critique of existing experimental or theoretical work.
The service of Open Peer Commentary will be primarily devoted to original unpublished manuscripts written specifically for INR treatment.
Controversiality simpliciter is not a sufficient criterion for soliciting Commentary: a paper may be controversial simply because it is wrong or weak. Some appropriate rationales for seeking Open Peer
Commentary would be that:
(1) the material bears in a significant way on some current controversial issues in imaging and radiological sciences; (2) its findings substantively contradict some well established aspects of current research and theory; (3) it criticizes the findings, practices, or principles of an accepted or influential line of work; (4) it unifies a substantial amount of disparate research; (5) it has important cross-disciplinary ramifications; (6) it introduces an innovative methodology or formalism for broader consideration; (7) it meaningfully integrates a body imaging data; (8) it places a hitherto dissociated area of research into broader medical perspective; etc. In order to assure communication with potential commentators (and readers) from other INR specialty areas, all technical terminology must be very clearly defined or simplified, and specialized concepts must be fully described. In case of doubt of appropriateness for INR commentary, authors should e-mail marco.leonardi@centauro.it detailing their proposal for the submission before submitting the entire electronic paper.
A note on commentaries: The purpose of the Open Peer Commentary service is to provide a concentrated constructive interaction between author and commentators on a topic judged to be of broad significance to the imaging and medical community. Commentators should provide substantive criticism, interpretation, and elaboration as well as any pertinent complementary or supplementary material, such as illustrations; all original data will be refereed in order to assure the archival validity of INR commentaries. Commentaries and articles should be free of hyperbole and remarks ad hominem.
Style and format for target articles: Target Articles must not exceed 4,500 words (and should ordinarily be considerably shorter); commentaries should not exceed 800 words, excluding references. Spelling, capitalization, and punctuation should be consistent within each article and commentary and should follow the style recommended in the latest edition of A Manual of Style, The University of Chicago Press. It is advisable to examine a recent issue of INR as a model. Target articles should be submitted in MSWord format as an email attachment to http://www.editorialmanager.com/in/. (RTF, PDF, or HTML formats are also acceptable). Figures should appear in the body of the text, not at the end of the paper, and must be supplied as separate TIFF, EPS, JPEG, or GIF files. However, if your article is accepted, TIFF or EPS format will be requested for publication since printing requires resolutions of at least 1100 dpi. (Please note that costs for color figure reproduction will be passed along to the author. Color printing is expensive, and authors are encouraged to find alternative methods for presentation of their argument.) INR temporarily archives the manuscript submitted for refereeing to a (nonpublic) Web Site accessible to the selected referees only. This is to accelerate and facilitate the refereeing process; after refereeing is completed, your manuscript will be removed; once accepted, the pre-copy-edited final draft will then be archived publicly for potential commentators. The copyedited final draft will be posted for the invited commentators. Please make sure your target article file has ALL of the following in this order:
Four Separate Word Counts (for the abstract, main text, references, and entire text—total + addresses etc.), an Indexable Title, Full Name(s), Institutional Address(es), E-mail Address(es) and Homepage URL(s) for all authors (where available), Short Abstract (100 words), Long Abstract (250 words), 5-10 Keywords (in alphabetical order), approx. 4,500 word Main Text (with paragraphs separated by full blank lines, not tab indents), and Alphabetical Reference List (maximum 20). Target article authors must also provide numbered headings and subheadings to facilitate cross-reference by commentators. Tables and figures (i.e., photographs, graphs, charts, or other artwork) should be numbered consecutively and should appear in its appropriate location. Every table should have a title; every figure, a caption.
Endnotes and appendices should be grouped together at the end of the paper and should ideally be locally linked to in the text to facilitate the reader (and of course the referee’s task). Acknowledgements should be placed at the end of the paper. The short abstract will appear by way of an advertisement, one issue in advance of the publication issue. The long abstract will be circulated to referees and then potential commentators should the paper be accepted, and will appear with the printed article. INR’s rigorous timetable constraints (requiring the coordination of target articles, commentaries and author’s responses within the publishing queue) make it extremely difficult for us to process follow-up drafts of your submission. Please make sure that the paper you submit is the carefully checked final draft to which you wish the referees to address. Please also ensure that your submission has been proof-read by a native English speaker before submission. This, of course, greatly improves its chances at the refereeing stage.
References:
INR format
Editing: The publishers reserve the right to edit and proof all articles and commentaries accepted for publication. Authors of target articles will be given the opportunity to review the copy-edited manuscript and page proofs. Commentators will be asked to review copy-editing only when changes have been substantial; commentators will not see proofs. Both authors and commentators should notify the editorial office of all corrections within 48 hours or approval will be assumed.
Author response to commentaries: All invited commentaries received before the deadline are posted as they are received to a hidden URL only accessible to the Authors and Editors. Authors are notified of this hidden URL once the commentary invitations have been sent. Please note that no commentary is officially accepted until the Editor in charge has formally reviewed it and notified both the authors and the Editorial Coordinator. Authors of target articles receive 20 offprints of the entire treatment, and can purchase additional copies. Commentators will also be given an opportunity to purchase offprints of the entire treatment.
Editorial Board
Editorial Information
Founded by
Pierrre L. Lasjaunias and Marco Leonardi
Editor-in-Chief:
Karel ter Brugge - Diagnostic and Interventional Neuroradiology
Toronto Western Hospital- 339, Bathurst Street M5T 2S8 Toronto Canada
e-mail: karel.terbrugge@uhn.on.ca
Assistant Editor:
Prof. Timo Krings
Diagnostic and Interventional Neuroradiology
Toronto Western Hospital
339, Bathurst Street
M5T 2S8 Toronto Canada
e-mail: timo.krings@uhn.on.ca
Editorial Board
Michel Mawad, Luc Picard
Corresponding Editors
Alex Berenstein, Robert Kwok, Luis A. LemmePlaghos, Akira Takahashi, Anton Valavanis,Fernando Viñuela
Advisory Board
Z. Bien, J.-F. Bonneville, G.B. Bradac, P. Burrows, A. Casasco, I.S. Choi,H. Deramond, J. Dion, L. Feng,A. Fox, K. Goto, G. Guglielmi, V. Halbach, H. Houdart, D. Kuehne, J.F. Meder, J.J. Merland, A. Molyneux, J. Moret, P.H. Nakstad, M. Negoro, L.R. Piske, B. Richling, G. Rodesch, Ch. Strother, P. Svendsen, S. Suthipongchai, A. Takahashi, W. Taki, J. TevahCastello, J. Theron, B. Willinsky, H. Zeumer
Publishing Staff
Publisher
Nicola Leonardi
Direttore responsabile
Centauro s.r.l.
Via del Pratello, 8
I-40122 Bologna, Italy
Language Editor
Anne Collins
e-mail: collins@iol.it
Graphic and Paging
Elisabetta Madrigali
E-mail: elisabetta@centauro.it
Advertising and Subscriptions
Serena Preti
E-mail: serena.preti@centauro.it
For Information:
Centauro s.r.l.
Via del Pratello, 8
I-40122 Bologna, Italy
Tel: ..39.051.227634
Fax: ..39.051.220099
SINGLE ISSUE: Euro 46,00
Back Issues: 50% surcharge
Reg. Trib. di Bologna n. 7636 del 16/06/06
ISSN 1591-0199
|
